Guangdong Biolight Meditech Co., Ltd. (SHE:300246)
China
· Delayed Price · Currency is CNY 14.00
+1.02 (7.86%)
Mar 10, 2026, 3:04 PM CST
SHE:300246 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 648.3 | 466.39 | 498.72 | 437.03 | 336.55 | 430.86 | Upgrade
|
| Short-Term Investments | - | 263.97 | 322.21 | 342.83 | - | - | Upgrade
|
| Trading Asset Securities | 18.48 | - | - | - | - | 52.2 | Upgrade
|
| Cash & Short-Term Investments | 666.78 | 730.35 | 820.93 | 779.86 | 336.55 | 483.06 | Upgrade
|
| Cash Growth | 49.31% | -11.03% | 5.27% | 131.72% | -30.33% | 159.83% | Upgrade
|
| Accounts Receivable | 265.45 | 262.44 | 261.25 | 297.24 | 232.03 | 191.8 | Upgrade
|
| Other Receivables | 22.75 | 54.72 | 27.59 | 25.22 | 26.26 | 13.89 | Upgrade
|
| Receivables | 288.2 | 317.16 | 288.84 | 322.46 | 258.29 | 205.69 | Upgrade
|
| Inventory | 281.68 | 232.07 | 220.37 | 200.57 | 193.5 | 148.18 | Upgrade
|
| Other Current Assets | 51.11 | 54.1 | 41.26 | 33 | 41.41 | 29.53 | Upgrade
|
| Total Current Assets | 1,288 | 1,334 | 1,371 | 1,336 | 829.76 | 866.46 | Upgrade
|
| Property, Plant & Equipment | 893.32 | 911.18 | 888.73 | 737.85 | 584.72 | 442.18 | Upgrade
|
| Long-Term Investments | 12.93 | 13.84 | 8.53 | 8.69 | 9.83 | 5.5 | Upgrade
|
| Goodwill | 25.15 | 25.15 | 40.67 | 127.13 | 127.13 | 136.59 | Upgrade
|
| Other Intangible Assets | 107.16 | 101.63 | 98.08 | 94.51 | 90.51 | 89.38 | Upgrade
|
| Long-Term Accounts Receivable | 12.34 | 4.12 | 5.59 | - | - | - | Upgrade
|
| Long-Term Deferred Tax Assets | 34.45 | 29.19 | 18.13 | 25 | 10.48 | 6.03 | Upgrade
|
| Long-Term Deferred Charges | 37.93 | 39.81 | 40.85 | 25.91 | 31.85 | 30.13 | Upgrade
|
| Other Long-Term Assets | 116.9 | 40.21 | 62.43 | 83.97 | 35.24 | 30.9 | Upgrade
|
| Total Assets | 2,528 | 2,499 | 2,534 | 2,439 | 1,720 | 1,607 | Upgrade
|
| Accounts Payable | 219.68 | 206.49 | 246.8 | 221.26 | 178.44 | 133.13 | Upgrade
|
| Accrued Expenses | 13.19 | 43.5 | 38.87 | 49.57 | 37.35 | 57.31 | Upgrade
|
| Short-Term Debt | 159.43 | 188.14 | 220.41 | 132.64 | 130.66 | 105.5 | Upgrade
|
| Current Portion of Long-Term Debt | 247.27 | 40.7 | 50.37 | 14.55 | 8.06 | - | Upgrade
|
| Current Portion of Leases | - | 6.65 | 6.45 | 5.95 | 4.47 | - | Upgrade
|
| Current Income Taxes Payable | 4.37 | 1.98 | 3.08 | 3.98 | 3.37 | 7.17 | Upgrade
|
| Current Unearned Revenue | 50.06 | 43.75 | 69.39 | 76.01 | 48.08 | 47.65 | Upgrade
|
| Other Current Liabilities | 102.04 | 144.61 | 135.34 | 99.43 | 86.77 | 43.89 | Upgrade
|
| Total Current Liabilities | 796.05 | 675.82 | 770.7 | 603.39 | 497.2 | 394.65 | Upgrade
|
| Long-Term Debt | 277.18 | 388.05 | 284.16 | 252.97 | 205.21 | 162.21 | Upgrade
|
| Long-Term Leases | 19.1 | 22.19 | 23.61 | 21.46 | 8.12 | - | Upgrade
|
| Long-Term Unearned Revenue | 135.94 | 106.94 | 50.3 | 45.38 | 9.32 | 10.4 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 12.79 | 14.72 | 14.87 | 13.48 | 7.25 | 7.07 | Upgrade
|
| Other Long-Term Liabilities | - | - | 1.81 | - | 0.03 | - | Upgrade
|
| Total Liabilities | 1,241 | 1,208 | 1,145 | 936.68 | 727.13 | 574.33 | Upgrade
|
| Common Stock | 264.58 | 264.58 | 264.58 | 175.79 | 146.09 | 146.09 | Upgrade
|
| Additional Paid-In Capital | 408.06 | 408.04 | 408.03 | 504.38 | - | 15.83 | Upgrade
|
| Retained Earnings | 504.7 | 513.04 | 584.48 | 684.82 | 698.15 | 701.16 | Upgrade
|
| Treasury Stock | -20.01 | -20.01 | - | - | - | - | Upgrade
|
| Comprehensive Income & Other | 54.58 | 53.04 | 53.81 | 51.09 | 49.64 | 54.85 | Upgrade
|
| Total Common Equity | 1,212 | 1,219 | 1,311 | 1,416 | 893.89 | 917.93 | Upgrade
|
| Minority Interest | 74.99 | 72.43 | 78.05 | 86.17 | 98.49 | 114.9 | Upgrade
|
| Shareholders' Equity | 1,287 | 1,291 | 1,389 | 1,502 | 992.38 | 1,033 | Upgrade
|
| Total Liabilities & Equity | 2,528 | 2,499 | 2,534 | 2,439 | 1,720 | 1,607 | Upgrade
|
| Total Debt | 702.98 | 645.72 | 584.99 | 427.57 | 356.52 | 267.71 | Upgrade
|
| Net Cash (Debt) | -36.21 | 84.63 | 235.94 | 352.29 | -19.97 | 215.35 | Upgrade
|
| Net Cash Growth | - | -64.13% | -33.03% | - | - | 12617.43% | Upgrade
|
| Net Cash Per Share | -0.14 | 0.32 | 0.89 | 1.35 | -0.09 | 0.98 | Upgrade
|
| Filing Date Shares Outstanding | 261.61 | 261.6 | 264.58 | 263.68 | 262.22 | 219.13 | Upgrade
|
| Total Common Shares Outstanding | 261.61 | 261.6 | 264.58 | 263.68 | 219.14 | 219.13 | Upgrade
|
| Working Capital | 491.71 | 657.87 | 600.7 | 732.5 | 332.56 | 471.81 | Upgrade
|
| Book Value Per Share | 4.63 | 4.66 | 4.95 | 5.37 | 4.08 | 4.19 | Upgrade
|
| Tangible Book Value | 1,080 | 1,092 | 1,172 | 1,194 | 676.25 | 691.96 | Upgrade
|
| Tangible Book Value Per Share | 4.13 | 4.17 | 4.43 | 4.53 | 3.09 | 3.16 | Upgrade
|
| Buildings | - | 582.36 | 308.84 | 244.21 | 216.58 | 224.73 | Upgrade
|
| Machinery | - | 448.39 | 418.44 | 398.3 | 361.28 | 283.82 | Upgrade
|
| Construction In Progress | - | 127.92 | 365.74 | 263.45 | 155.7 | 71.99 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.